Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Hepatocellular Carcinoma”

224 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 224 results

Large-scale testing (Phase 3)UnknownNCT03516448
What this trial is testing

Expanding Phase III Study of Tyroserleutide for Injection

Who this might be right for
Hepatocellular Carcinoma
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 352
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Large-scale testing (Phase 3)Study completedNCT01313377
What this trial is testing

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
UNICANCER 190
Large-scale testing (Phase 3)Looking for participantsNCT06618664
What this trial is testing

Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevacizumab for the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 590
Large-scale testing (Phase 3)Ended earlyNCT04985136
What this trial is testing

Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Jiangsu HengRui Medicine Co., Ltd. 1
Large-scale testing (Phase 3)Active Not RecruitingNCT03298451
What this trial is testing

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,324
Large-scale testing (Phase 3)Temporarily pausedNCT05033522
What this trial is testing

Immunotherapy for Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Mirror Biologics, Inc. 150
Large-scale testing (Phase 3)Looking for participantsNCT07166406
What this trial is testing

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Who this might be right for
Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8
NRG Oncology 252
Testing effectiveness (Phase 2)Looking for participantsNCT05412589
What this trial is testing

MFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC

Who this might be right for
Stage III Hepatocellular Cancer (CNLC Staging)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 35
Large-scale testing (Phase 3)UnknownNCT05062837
What this trial is testing

Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 62
Early research (Phase 1)Temporarily pausedNCT06968195
What this trial is testing

Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaRecurrent Hepatocellular Carcinoma+3 more
Roswell Park Cancer Institute 24
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)WithdrawnNCT03217253
What this trial is testing

Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction

Who this might be right for
Ann Arbor Stage III B-Cell Non-Hodgkin LymphomaAnn Arbor Stage IV B-Cell Non-Hodgkin LymphomaMetastatic Malignant Solid Neoplasm+8 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT03960008
What this trial is testing

Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant

Who this might be right for
Hepatocellular CarcinomaHCC
Lahey Clinic 9
Large-scale testing (Phase 3)UnknownNCT03859128
What this trial is testing

Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 402
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Not applicableActive Not RecruitingNCT03896646
What this trial is testing

Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)

Who this might be right for
Stage III Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8+4 more
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Large-scale testing (Phase 3)Looking for participantsNCT06844357
What this trial is testing

A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.

Who this might be right for
HCC
Zhejiang Raygene Pharmaceuticals Co., Ltd 300
Large-scale testing (Phase 3)Looking for participantsNCT06921785
What this trial is testing

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 1,220
Load More Results